{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T03:46:03Z","timestamp":1792381563360,"version":"4.4.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2133.2009.09210.x","type":"journal-article","created":{"date-parts":[[2009,4,11]],"date-time":"2009-04-11T03:44:03Z","timestamp":1239421443000},"page":"904-909","source":"Crossref","is-referenced-by-count":23,"title":["Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study"],"prefix":"10.1093","volume":"161","author":[{"given":"P.","family":"Saiag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bauhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bouscarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","article-title":"Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)","volume":"47","author":"Aubin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.23092","article-title":"Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/172.1.235","article-title":"Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women","volume":"172","author":"Chirgwin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9378(91)90620-7","article-title":"Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection","volume":"164","author":"Matorras","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(94)70236-5","article-title":"Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)","volume":"31","author":"Smith","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB7","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1073\/pnas.91.7.2436","article-title":"Genital human papillomavirus infection","volume":"91","author":"Lowy","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/jid.2008.24","article-title":"Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men","volume":"128","author":"Kreuter","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9343(97)00181-2","article-title":"Therapeutic approaches to genital warts","volume":"102","author":"Beutner","year":"1997","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.2009.09210.x-BIB11","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jcv.2004.12.005","article-title":"Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination","volume":"32","author":"Stern","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0020-7292(95)02339-E","article-title":"Interferon as an adjuvant treatment for genital condyloma acuminatum","volume":"49","author":"Klutke","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.58.3.365","article-title":"Cytokine induction by the immunomodulators imiquimod and S-27609","volume":"58","author":"Testerman","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-1-3","article-title":"Imiquimod for the treatment of genital warts: a quantitative systematic review","volume":"1","author":"Moore","year":"2001","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB16","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/00002030-199912030-00011","article-title":"A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group","volume":"13","author":"Gilson","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","article-title":"Karnofsky performance status revisited: reliability, validity, and guidelines","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/095646204322637191","article-title":"5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy","volume":"15","author":"Cusini","year":"2004","journal-title":"Int J STD AIDS"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1468-3083.2007.02169.x","article-title":"Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia","volume":"21","author":"Sanclemente","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB21","first-page":"367","article-title":"Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse","volume":"13","author":"Drobacheff","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.11222","article-title":"Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study","volume":"106","author":"Dalstein","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcv.2004.02.008","article-title":"High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women","volume":"31","author":"Pretet","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198710153171601","article-title":"Sexual practices, sexually transmitted diseases, and the incidence of anal cancer","volume":"317","author":"Daling","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/archderm.142.11.1438","article-title":"Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men","volume":"142","author":"Wieland","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB27","first-page":"602","article-title":"Eradication of basal cell cancer in an HIV positive patient with topical imiquimod","volume":"3","author":"Scott","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09210.x-BIB28","first-page":"278","article-title":"Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report","volume":"12","author":"Nunes","year":"2004","journal-title":"Acta Dermatovenerol Croat"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09210.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09210.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:45:21Z","timestamp":1676382321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/4\/904\/6642117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09210.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}